How would you compare that gene therapy vis a vis the cell therapy of OCAT for, so far, other eye conditions that also lead to blindness, like dryAMD and Stargardt's macular degeneration[dystrophy]?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.